SPARC-Europe is pleased to announce its first in-person event, "Harnessing the Opportunities of Radioligand Therapies: Infrastructure and Education," taking place at the European Parliament in Brussels on 2 May, from 12:30 to 14:30. Hosted by MEP Helmut Geuking, the event aims to gather experts in the oncology field, patient advocates, and Members of the European Parliament to discuss the current state of hospital infrastructures and capacities for RLTs across the EU, as well as the availability of regional funds for their uptake and delivery.
The event will feature esteemed speakers, including:
- MEP Helmut Geuking, who is a political patron of SPARC-Europe and a strong advocate for advancing RLTs in Europe.
- Mark McDonnell, President of the International Neuroendocrine Cancer Alliance (INCA), will give INCA’s patient perspective and outline the importance of RLTs in improving patient outcomes.
- Dr. Nicola Fazio, Director of the Unit of Gastrointestinal Medical Oncology and Neuroendocrine Tumours of the European Institute of Oncology (IEO), will share his expertise on the multidisciplinary teams for RLT in the context of NET patients. .
- Maria Luisa De Rimini, President of the Italian Association of Nuclear Medicine and Molecular Imaging (AIMN), will present RevoLuTion’s White Book on RLT and the challenges of the implementation in clinical practice.
- Arturo Cavaliere, President of the Italian Society of Hospital Pharmacy (SIFO), will provide insights focused on the training of medical personnel.
- MEP Brando Benifei, also a political patron of SPARC-Europe, will offer his views on the policy efforts needed to support RLTs in Europe.
- Marco Di Donato, Policy and Project Officer at European Regional and Local Health Authorities (EUREGHA), will discuss the promotion of education projects at the regional level during his presentation.
- Prof. Dr. Christophe Deroose, Deputy Head of Clinic, Nuclear Medicine, University Hospitals Leuven & Full Professor, Nuclear Medicine and Molecular Imaging, KU Leuven (Belgium), will share his expertise on the role of nuclear medicine and molecular imaging in RLTs and will introduce the RLT Academy as the first Erasmus + supported RLT initiative.
Follow this link to view the complete agenda!
The event will provide a platform for discussions on the current status of RLT infrastructures, capacities, and funding opportunities across the EU, as well as the challenges and opportunities in implementing RLTs in clinical practice. It will also highlight the importance of policy efforts at the European level to support the advancement of RLTs and ensure that policy frameworks are aligned with the unique features of these therapies.
SPARC-Europe invites all stakeholders interested in the advancement of RLTs, including policymakers, oncologists, patient advocates, and other healthcare professionals, to join this timely event at the European Parliament on 2 May.
You may register for the event via this link!